Interdisciplinary Working Group for Movement Disorders
Randomized trial of botulinum toxin to prevent pes cavus progression in pediatric charcot-marie-tooth disease type 1A: Burns J et al.
Musscle Nerve 42: 262–267, 2010
Authors
JOSHUA BURNS, PhD, 1,2
ADAM SCHEINBERG, MMed, 3,4
MONIQUE M. RYAN, MMed, 5
KRISTY J. ROSE, MHSc, 2
and ROBERT A. OUVRIER, MD, 2
Author Details
1 Faculty of Health Sciences, University of Sydney, Sydney, New South Wales, Australia
2 Institute for Neuroscience and Muscle Research, Children’s Hospital at Westmead, Locked Bag 4001, Sydney,New South Wales 2145, Australia
3 Department of Rehabilitation, The Children’s Hospital at Westmead, Sydney, New South Wales, Australia
4 Victorian Paediatric Rehabilitation Service, Victoria, Australia
5 Children’s Neuroscience Centre, Royal Children’s Hospital/Murdoch Children’s Research Institute/Department of Paediatrics,Faculty of Medicine, University of Melbourne, Victoria, Australia
Botulinum toxin type A in the treatment of lower-limb spasticity in children with cerebral palsy: Camargo CHF et al.
Arq Neuropsiquiatr 2009;67(1):62-68
Authors
Carlos Henrique F. Camargo
Hélio A.G. Teive
Marise Zonta
Gilmar C. Silva
Marcelo R. Oliveira
Maurício M. Roriz
Ivar V. Brandi
Nilson Becker
Rosana Hermínia Scola
Lineu César Werneck
The management of spastic equinus in cerebral palsy: Cobeljic G et al.
2009, Orthopaedics and Trauma 23:3
Authors
Goran Cobeljic
Marko Bumbasirevic
Aleksandar Lesic
Zoran Bajin
Marko Bumbasirevic
Aleksandar Lesic
Zoran Bajin
A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force: Albanese A M et al.
European Journal of Neurology 2006, 13: 433–444
doi:10.1111/j.1468-1331.2006.01537.x
Authors
Membership: A. Albanese (chairman) a,
M. P. Barnes b,
K. P. Bhatia c,
E. Fernandez-Alvarez d,
G. Filippini a,
T. Gasser e,
J. K. Krauss f,
A. Newton g,
I. Rektor h,
M. Savoiardo a,
J. Valls-Sole` i
Author Details
a Istituto Nazionale Neurologico Carlo Besta, Milan, Italy;
b Hunters Moor Regional Rehabilitation Centre, Newcastle Upon Tyne, UK;
c Institute of Neurology, University College London, Queen Square, London, UK;
d Neuropediatric Department, Hospital San Joan de Dieu, Barcelona, Spain;
e Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Germany;
f Department of Neurosurgery, Medical University of Hanover, MHH, Hannover, Germany;
g European Dystonia Federation,Brussels, Belgium;
h First Department of Neurology, Masaryk University, St. Anne’s Teaching Hospital, Brno, Czech Republic; and
i Neurology Department, Hospital Clı´ nic, Barcelona, Spain
Split-Screen Video Demonstration of Sonography-Guided Muscle Identification and Injection of Botulinum Toxin: Fietzek U M et al.
Movement Disorders
Vol. 25, No. 13, 2010, pp. 2225–2252
2010 Movement Disorder Society
Authors
Urban M. Fietzek, MD, 1
A. Sebastian Schroeder, MD, 2
Joerg Wissel, MD, PhD, 3
Florian Heinen, MD, PhD, 2
and Steffen Berweck, MD, PhD 2,4 *
Author Details:
1 Neurologisches Krankenhaus Muuenchen, Center for Parkinson’s Disease and Movement Disorders, Muuenchen, Germany;
2 Department of Pediatric Neurology and Developmental Medicine, Dr. von Hauners’ Children’s Hospital, Ludwig-Maximilians-University Munich, Muuenchen, Germany;
3 Neurologische Rehabilitationsklinik, Beelitz-Heilstaaetten, Beelitz-Heilstaaetten, Germany;
4 Treatment Centre Vogtareuth, Specialist Centre for Neuropediatric Rehabilitation, Vogtareuth, Germany
International Neurology – A Clinical Approach: (Editors) Lisak RP et al.
2009, A Clinical Approach
This edition first published 2009, ©2009 by Blackwell Publishing Ltd
EDITED BY
ROBERT P. LISAK MD FAAN FRCP
Parker Webber Chair in NeurologyProfessor and Chair of NeurologyProfessor of Immunology and MicrobiologyWayne State University School of Medicine;Neurologist-in-Chief, Detroit Medical CenterChief of Neurology, Harper University HospitalDetroit, MI, USA
DANIEL D. TRUONG MD FAAN
Head of The Parkinson and Movement Disorder InstituteMemorial Neuroscience InstituteOrange Coast Memorial Medical CenterFountain Valley, CA, USA
WILLIAM M. CARROLL MBBS MD FRACP FRCP(E)
Head of Neurology and Clinical NeurophysiologySir Charles Gairdner HospitalNedlands, Perth, Australia
ROONGROJ BHIDAYASIRI MD FRCP
DirectorChulalongkorn Comprehensive Movement Disorders CenterChulalongkorn University HospitalBangkok, Thailand;University of California at Los AngelesLos Angeles, CA, USA
FOREWORD BY JOHN WALTON (LORD WALTON OF DETCHANT
Treatments for spasticity and pain in multiple sclerosis: a systematic review: Beard S et al.
Health Technol Assess 2003; 7 (40).
Authors
S Beard A Hunn J Wight
School of Health and Related Research (ScHARR),University of Sheffield, UK
Botulinum Toxin Type a for Upper Limb Spasticity Following Stroke: An Open-Label Study With Individualised, Flexible Injection Regimens: Slawek J et al.
Neurol Sci (2005) 26:32–39
DOI 10.1007/s10072-005-0379-8
DOI 10.1007/s10072-005-0379-8
Authors
J. Slawek, A. Bogucki, D. Reclawowicz
Best Clinical Practice in Botulinum Toxin Treatment for Children with Cerebral Palsy: Strobl W et al.
Intrathecal Baclofen for Spastic Hypertonia From Stroke Editorial Comment: Meythaler JM et al.
Management of Spasticity Associated Pain with Botulinum Toxin A: Wissel J et al.
2000, Journal of Pain and Symptom Management, Vol. 20 No. 1 July 2000
Author Details
Jörg Wissel, MD, Jörg Müller, MD, Jürgen Dressnandt, MD, Florian Heinen, MD, Markus Naumann, MD, Helge Topka, MD, and Werner Poewe, MD
Department of Neurology (J.W., J.M., W.P.), University of Innsbruck, Innsbruck, Austria; Hospital forNeurology (J.D.), Bad Aibling; Department of Neuropediatrics (F.H.), University of Freiburg, Freiburg; Department of Neurology (M.N.), University of Würzburg, Würzburg; and Department of Neurology(H.T.), University of Tübingen, Tübingen, Germany
Abstracts of Scientific Papers and Posters Presented at the Annual Meeting of the Association of Academic Physiatrists Medical Student Category Award Winner TUNING ALGORITHMS FOR CONTROL INTERFACES FOR USERS WITH UPPER LIMB IMPAIRMENTS: Zhou L
Unsere Zertifizierer
